The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
NVAX · Healthcare · Narrow moat
On the watchlist
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | NAGE | DCTH | NVAX | CDRE |
|---|---|---|---|---|
| Moat Score (0–100) | 62 (highest) | 62 (highest) | 62 (highest) | 61 |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 85 | 70 | 54 | 89 (highest) |
| Pricing power | 91 | 94 (highest) | 76 | 68 |
| Returns on capital | 8 | 0 | — | 52 (highest) |
| Balance-sheet safety | 100 (highest) | 100 (highest) | 73 | 71 |
| Capital allocation | 24 | 44 (highest) | 44 (highest) | 28 |
| No price data | No price data | No price data | 150% above value if growth stopped today | |
| Market cap | $256M | $424M | $1.2B | $1.3B |
| Moat tier | Narrow moat | Narrow moat | Narrow moat | Narrow moat |
| Filing date | FY2025 | FY2025 | FY2025 | FY2025 |